Cornerstone Advisors (Washington)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,187
Closed -$217K 775
2019
Q3
$217K Buy
2,187
+137
+7% +$13K 0.03% 78
2019
Q2
$190K Buy
2,050
+162
+9% +$15.4K 0.02% 161
2019
Q1
$178K Buy
1,888
+379
+25% +$33.1K 0.02% 154
2018
Q4
$97K Sell
1,509
-159
-10% -$11.7K 0.02% 196
2018
Q3
$149K Buy
1,668
+131
+9% +$11.6K 0.1% 158
2018
Q2
$122K Sell
1,537
-27
-2% -$2.24K 0.08% 173
2018
Q1
$140K Sell
1,564
-57
-4% -$5.47K 0.1% 154
2017
Q4
$169K Sell
1,621
-12
-0.7% -$1.35K 0.11% 137
2017
Q3
$238K Hold
1,633
0.16% 88
2017
Q2
$212K Buy
1,633
+3
+0.2% +$368 0.12% 96
2017
Q1
$203K Hold
1,630
0.11% 92
2016
Q4
$189K Buy
1,630
+310
+23% +$34.5K 0.16% 95
2016
Q3
$138K Buy
1,320
+884
+203% +$95.7K 0.12% 124
2016
Q2
$43K Buy
436
+23
+6% +$2.38K 0.04% 171
2016
Q1
$41K Sell
413
-1,268
-75% -$131K 0.04% 179
2015
Q4
$201K Sell
1,681
-1,879
-53% -$217K 0.22% 57
2015
Q3
$385K Sell
3,560
-365
-9% -$45.3K 0.34% 35
2015
Q2
$454K Hold
3,925
0.37% 35
2015
Q1
$452K Hold
3,925
0.35% 37
2014
Q4
$439K Buy
3,925
+3,825
+3,825% +$403K 0.32% 45
2014
Q3
$9K Sell
100
-16
-14% -$1.44K 0.01% 209
2014
Q2
$10K Hold
116
0.01% 216
2014
Q1
$8K Buy
+116
New +$9.19K 0.01% 229

Other funds holding CELG

Cornerstone Advisors (Washington)'s CELG Position: Q4 2019 in Review

Cornerstone Advisors (Washington) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,187 shares — an estimated $217K sold.

Cornerstone Advisors (Washington) first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $454K in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cornerstone Advisors (Washington) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 2,187 Celgene Corp shares in Q4 2019, an estimated $217K.
  • Cornerstone Advisors (Washington) first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
  • Cornerstone Advisors (Washington)'s Celgene Corp position peaked at $454K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q4 2019, filed 30 Jan 2020.